Redefine Patient Care
Is your practice leading the way with innovative treatment options?
Tackle Pain and Aesthetic Concerns FAST
Learn about non-surgical, low-risk treatment options that allow you to stay active.
Set your practice apart by offering the regenerative solutions your patients are seeking.
FDA Approved Focused Shock Wave is the next generation of Extracorporeal Shock Wave Therapy (ESWT). High-quality workmanship and optimal ergonomics mark the design of the new focused shock wave generation with the SEPIA handpiece. The special flexibility of the handpiece cable supports non-tiring and, thus, easier treatment always directly at the patient – an important factor in the day-to-day work.
The DUOLITH® SD1 T-TOP Ultra with focused SEPIA® handpiece boasts integrated control elements as well as an optional 10” touch screen.
The control elements have all been integrated into the SEPIA handpiece which is compatible with all DUOLITH® SD1 Ultra systems ensuring that the treatment is easy and efficient. Frequency and energy level can be adjusted directly from the handpiece. Pre-set treatment parameters save time and allow for undisturbed working.
With its progressive technological advancements, Shock Wave Therapy (EPAT/ESWT) delivers an evidence-based, non-surgical solution for patients suffering from chronic heel pain. It addresses the increasing demand for patient convenience, less down-time and risk, as well as better clinical and economic outcomes, and improved practice efficiencies and cash-flow.
Health care professionals are using EPAT/ESWT to successfully treat pain associated with chronic proximal plantar fasciitis as well as other acute or chronic musculoskeletal pain associated with orthopedic issues to include:
Check out the study published in The Journal of Bone Joint Surgery “Clinically relevant effectiveness of focused extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis: a randomized, controlled multicenter study.”
The best way to advance patient care for your practice is looking to the evidence that’s available for new technologies and protocols. CuraMedix EPAT and ESWT solutions are backed by clinical studies and are evidence-based; whereas similar competing technologies cannot make this claim.